One research revealed that the inhibition of PDE4 elevates cAMP and enhances calcium currents in human atrial myocytes, leading to increased spontaneous calcium release and a heightened risk of arrhythmias during β-adrenergic stimulation [72]. Here, PDE4A is linked to cardiac arrhythmia.